RA Capital Management »

Seaport Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Seaport Therapeutics shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Seaport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seaport Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seaport Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 700k 21.72

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Seaport Therapeutics

Arch Venture Corp
Goldman Sachs Group
Canada Pension Plan Investment Board
Jpmorgan Chase & Co
RA Capital Management
Vanguard Capital Management
Braidwell
Perceptive Advisors
Principal Financial Group
Standard Life Aberdeen
Citadel Advisors
Pier Capital
Vanguard Fiduciary Trust
Pentwater Capital Management
ALPS Advisors

View all funds holding Seaport Therapeutics